PharmiWeb.com - Global Pharma News & Resources
11-Jun-2019

Meningococcal Vaccines Market Poised to Touch USD 9.37 Billion by 2026

Global Meningococcal Vaccines Market Size is expected to reach US$ 9.37 Billion by 2026 and will grow at a CAGR around 12.3 % during the forecast period.

The global Meningococcal Vaccines Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2019 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2019 to 2026.

Request a Sample Copy of this Research Report at https://www.acumenresearchandconsulting.com/request-sample/1397

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Meningococcal Vaccines Market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Meningococcal Vaccines Market market?
  • What is the market drivers, restrains, opportunities governing the global Meningococcal Vaccines Market Market?
  • Which is the largest and the fastest growing segments in the global Meningococcal Vaccines Market market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1397

Market Players:

Key market players are expanding their item run in created markets like the U.S to exhibit the effect of meningococcal vaccines in newborn children and meningococcal carriage in youths.

The episode of meningococcal meningitis is an extremely general wellbeing concern and keeping in mind that successful and moderate treatment alternatives are accessible in the worldwide market, the illness has been found to prompt a high rate of mortality and make long haul neurological imperfections in newborn children and youthful youngsters. Half of the bacterial meningitis cases are found in youngsters beneath five years old. The following age bunch vulnerable to the malady is the 15 ndash; 19 years class. Considering the dominating unfavorable effect of meningococcal meningitis on the youthful populace, top organizations like GlaxoSmithKline are dealing with extending their product offering ndash; including the expansion of new definitions ndash; to take into account this statistic.

Major companies contributing the global meningococcal vaccines market are Baxter International, Biomed Pvt. Ltd., GlaxoSmithKline plc, JN-International Medical Corporation, Novartis International, Nuron Biotech, Pfizer Inc., Sanofi SA, and Serum Institute of India Ltd.

The Major Market Segments of GlobalMeningococcal Vaccines Marketare as below:

Market Segmentation

Market Segmentation By Type:

  • Combination Vaccines
    • MenHibrix
    • Menitorix
  • Conjugate Vaccines
    • Menactra
    • MenAfriVac
    • Meningitec
    • Menjugate
    • Menveo
    • NeisVac-C
    • Nimenrix
    • NmVac4-DT
  • Polysaccharide
    • Mencevax
    • Menomune
    • NmVac4
    • Others
  • Men B Vaccines
    • Bexsero
    • Trumenba
  • Others

Market Segmentation By End User:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

Market Segmentation by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

CHAPTER 4. MENINGOCOCCAL VACCINES MARKET BY FORM

CHAPTER 5. MENINGOCOCCAL VACCINES MARKET BY END USER

CHAPTER 6. NORTH AMERICA MENINGOCOCCAL VACCINES MARKET BY COUNTRY

CHAPTER 7. EUROPE MENINGOCOCCAL VACCINES MARKET BY COUNTRY

CHAPTER 8. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET BY COUNTRY

CHAPTER 9. LATIN AMERICA MENINGOCOCCAL VACCINES MARKET BY COUNTRY

CHAPTER 10. MIDDLE EAST MENINGOCOCCAL VACCINES MARKET BY COUNTRY

CHAPTER 11. AFRICA MENINGOCOCCAL VACCINES MARKET BY COUNTRY

CHAPTER 12. COMPANY PROFILE

CHAPTER 13. RESEARCH APPROACH

To Purchase this Premium Report athttps://www.acumenresearchandconsulting.com/buy-now/0/1397

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 11-Jun-2019